A Study of Probiotics in IgA Nephropathy | MicrobiomeTrials← Back to trialsNCT06767592
A Study of Probiotics in IgA Nephropathy
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-10-13Est. Completion: 2025-08-31
Enrollment target: 18 participants Locations- Leicester General Hospital, University Hospitals of Leicester NHS Trust, Leicester, Leicestershire, United Kingdom
Other microbiome trials you might be interested in
IgA Nephropathy
This is a phase IIa, multicenter, single-arm, open-label study to evaluate the safety and efficacy of XH-S003 in patient…
Beijing, ChinaCompleted Apr 23, 2026
Immunoglobulin A Nephropathy (IgAN)Complement 3 Glomerulopathy (C3G)IC-MPGN
This is a Phase 2 study to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics of ADX-038 in adults …
Shenzhen, ChinaEst. completion Jul 10, 2028
Phase 1
Recruiting
This study is researching a particular group of experimental drugs administered for a short period in the treatment of p…
Rochester, United StatesEst. completion Sep 9, 2029